To investigate metastatic castration resistant prostate cancer patients treated with Abiraterone and/or Abiraterone and Enzalutamide associated with development of liver metastases
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Apr 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium